USFDA okays breathing device

Venkatesan R._5375 | Updated on July 06, 2018

The US Food and Drug Administration has approved a new device, the Zephyr Endobronchial Valve (Zephyr Valve), intended to treat breathing difficulty associated with severe emphysema, a note from the regulator said.

“Treatment options are limited for people with emphysema who have severe symptoms that have not improved from taking medicines,” said Tina Kiang, acting director, Division of Anaesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices, in the FDA’s Center for Devices and Radiological Health.

 “This device is a less invasive treatment that expands the options available to patients.”





Published on July 06, 2018

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor